Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results.WALTHAM, Mass. -- Oscient Pharmaceuticals Corporation (Nasdaq:OSCI) will release financial results for the fourth quarter and fiscal year ended December 31, 2006 on Tuesday, February 27, 2007 prior to the opening of the U.S. financial markets. A conference call will be held at 8:30 a.m. Eastern Time with Steven Rauscher, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , and other members of Oscient's management team. The Company announced preliminary revenue results for the fourth quarter on January 8, 2007. What: Fourth Quarter Financial Results When: February 27, 2007 at 8:30 am Eastern Time How: Domestic participants can access the call by dialing 1-888-634-4009. International participants are asked to dial 1-706-634-2285. The call will also be webcast through the Company's website at www.oscient.com. A replay will be available two hours after the conclusion of the call until March 6, 2007. Domestic participants can access the replay by dialing 1-800-642-1687, while international participants are asked to dial 1-706-645-9291. The conference ID number for the replay is 8411143. A replay will also be available through www.oscient.com. About Oscient Pharmaceuticals Oscient Pharmaceuticals Corporation is a commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force. ANTARA([R]) (fenofibrate) capsules is indicated for the adjunct treatment of hypercholesterolemia Hypercholesterolemia Definition Hypercholesterolemia refers to levels of cholesterol in the blood that are higher than normal. Description Cholesterol circulates in the blood stream. It is an essential molecule for the human body. (high blood cholesterol) and hypertriglyceridemia (high triglycerides Triglycerides Fatty compounds synthesized from carbohydrates during the process of digestion and stored in the body's adipose (fat) tissues. High levels of triglycerides in the blood are associated with insulin resistance. ) in combination with diet. FACTIVE Fac´tive a. 1. Making; having power to make. ([R]) (gemifloxacin mesylate gemifloxacin mesylate Factive Pharmacologic class: Quinolone Therapeutic class: Broad-spectrum anti-infective Pregnancy risk category C Action) tablets is an antibiotic approved for the treatment of acute bacterial exacerbations of chronic bronchitis and community-acquired pneumonia of mild to moderate severity. Oscient also has a novel, late-stage antibiotic candidate, Ramoplanin, under investigation for the treatment of Clostridium clostridiumAny of the rod-shaped, usually gram-positive bacteria (see gram stain) that make up the genus Clostridium. They are found in soil, water, and the intestinal tracts of humans and other animals. Some species grow only in the complete absence of oxygen. difficile-associated disease (CDAD CDAD Clostridium Difficile-Associated Diarrhea CDAD Component Data Administrator ). For important information regarding the safety and use of ANTARA and FACTIVE, please see the full prescribing information available at www.antararx.com and www.factive.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion